Clinical Trial Update: Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma [Phase 2]

View source ↗

Summary

This clinical trial entry reports a Phase 2 study evaluating zanubrutinib in combination with chemotherapy for newly diagnosed central nervous system lymphoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Ruijin Hospital | Conditions: Central Nervous System Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING